A new comprehensive review published in the journal Neuroscience & Biobehavioral Reviews finds growing evidence that ...

A randomized, double-blind clinical trial conducted at Buriram Hospital in Thailand found that daily sublingual cannabidiol (CBD) was safe for individuals with Parkinson’s disease and led to ...